✨ Medicinal Product Notices and Tuberculosis Vaccinator Approvals




NEW ZEALAND GAZETTE, No. 159

30 NOVEMBER 2006


Product:

Ciprofloxacin
Active Ingredient:
Ciprofloxacin hydrochloride 873mg equivalent to ciprofloxacin 750mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Bristol Pharma (New Zealand) Pty Limited
Manufacturer:
IPCA Laboratories Limited, Athal, Silvassa, Dadra and Nagar Haveli (U T), India

Product:

Enidin P
Active Ingredient:
Brimonidine tartrate 1.5mg/mL
Dosage Form:
Eye drops, solution
New Zealand Sponsor:
Allergan New Zealand Limited
Manufacturer:
Allergan Sales LLC, Waco, Texas, United States of America

Product:

Maxiclear Hayfever & Sinus Relief
Active Ingredients:
Loratadine 2.5mg
Phenylephrine hydrochloride 10mg
Dosage Form:
Tablet
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Matrix Laboratories Limited, Sinnar, Nashik, Maharashta, India

Product:

Maxiclear Sinus Relief
Active Ingredient:
Phenylephrine hydrochloride 10mg
Dosage Form:
Tablet
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Matrix Laboratories Limited, Sinnar, Nashik, Maharashta, India

Product:

Nicotinell Classic
Active Ingredient:
Nicotine 2mg
Dosage Form:
Chewing gum
New Zealand Sponsor:
Novartis Consumer Health Australasia Pty Limited
Manufacturer:
Fertin Pharma A/S, Vejle, Denmark

Product:

Nicotinell Classic
Active Ingredient:
Nicotine 4mg
Dosage Form:
Chewing gum
New Zealand Sponsor:
Novartis Consumer Health Australasia Pty Limited
Manufacturer:
Fertin Pharma A/S, Vejle, Denmark

Product:

Procip
Active Ingredient:
Ciprofloxacin hydrochloride 291mg equivalent to ciprofloxacin 250mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Bristol Pharma (New Zealand) Pty Limited
Manufacturer:
IPCA Laboratories Limited, Athal, Silvassa, Dadra and Nagar Haveli (U T), India

Product:

Procip
Active Ingredient:
Ciprofloxacin hydrochloride 582mg equivalent to ciprofloxacin 500mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Bristol Pharma (New Zealand) Pty Limited
Manufacturer:
IPCA Laboratories Limited, Athal, Silvassa, Dadra and Nagar Haveli (U T), India

Product:

Procip
Active Ingredient:
Ciprofloxacin hydrochloride 873mg equivalent to ciprofloxacin 750mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Bristol Pharma (New Zealand) Pty Limited
Manufacturer:
IPCA Laboratories Limited, Athal, Silvassa, Dadra and Nagar Haveli (U T), India

Dated this 23rd day of November 2006.

BARRY BORMAN, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go8317


Tuberculosis Regulations 1951

Notice of Approval of Tuberculosis Vaccinators

Under the Tuberculosis Regulations 1951

Pursuant to Regulation 6 (4) of the Tuberculosis Regulations 1951, the Director-General of Health hereby gives notice that the following persons have been approved to perform vaccination against tuberculosis.

Name Address Date of Approval
Susan Stewart Napier 30 June 2006
Fiona Jackson Havelock North 30 June 2006
Toni Searl R.D. 1, Lyttelton 12 June 2006
Janet Steam Tauranga 21 July 2006
Natalie Haenga-Parata Gisborne 16 August 2006


Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2006, No 159


Gazette.govt.nz PDF NZ Gazette 2006, No 159





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of Ciprofloxacin 500mg (continued from previous page)

πŸ₯ Health & Social Welfare
23 November 2006
Medicines, Distribution, Consent, Ciprofloxacin, Bristol Pharma
  • BARRY BORMAN, Acting Deputy Director-General, Public Health

πŸ₯ Approval of Tuberculosis Vaccinators

πŸ₯ Health & Social Welfare
Tuberculosis, Vaccination, Approval, Health Regulations
  • Susan Stewart, Approved to perform tuberculosis vaccination
  • Fiona Jackson, Approved to perform tuberculosis vaccination
  • Toni Searl, Approved to perform tuberculosis vaccination
  • Janet Steam, Approved to perform tuberculosis vaccination
  • Natalie Haenga-Parata, Approved to perform tuberculosis vaccination

  • Director-General of Health